Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Supplementation of Gangliosides - A Potential Treatment for GM3 Synthase Deficiency

NCT02234024 is registered in ClinicalTrials.gov with DDC Clinic - Center for Special Needs Children as lead sponsor.

NCT NCT02234024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02234024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Supplementation of Gangliosides - A Potential Treatment for GM3 Synthase Deficiency
Lead sponsor
DDC Clinic - Center for Special Needs Children
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2020
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gm3 synthase deficiency